Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study.
Godeau B, Porcher R, Fain O, Lefrère F, Fenaux P, Cheze S, Vekhoff A, Chauveheid MP, Stirnemann J, Galicier L, Bourgeois E, Haiat S, Varet B, Leporrier M, Papo T, Khellaf M, Michel M, Bierling P. Godeau B, et al. Among authors: bierling p. Blood. 2008 Aug 15;112(4):999-1004. doi: 10.1182/blood-2008-01-131029. Epub 2008 May 7. Blood. 2008. PMID: 18463354 Free article. Clinical Trial.
Antiphospholipid antibodies in adults with immune thrombocytopenic purpura.
Pierrot-Deseilligny Despujol C, Michel M, Khellaf M, Gouault M, Intrator L, Bierling P, Godeau B. Pierrot-Deseilligny Despujol C, et al. Among authors: bierling p. Br J Haematol. 2008 Aug;142(4):638-43. doi: 10.1111/j.1365-2141.2008.07228.x. Epub 2008 May 28. Br J Haematol. 2008. PMID: 18510681 Free article.
A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopenia.
Khellaf M, Viallard JF, Hamidou M, Cheze S, Roudot-Thoraval F, Lefrere F, Fain O, Audia S, Abgrall JF, Michot JM, Dauriac C, Lefort S, Gyan E, Niault M, Durand JM, Languille L, Boutboul D, Bierling P, Michel M, Godeau B. Khellaf M, et al. Among authors: bierling p. Haematologica. 2013 Jun;98(6):881-7. doi: 10.3324/haematol.2012.074633. Epub 2013 Feb 26. Haematologica. 2013. PMID: 23445876 Free PMC article.
Efficacy and safety of rituximab given at 1,000 mg on days 1 and 15 compared to the standard regimen to treat adult immune thrombocytopenia.
Mahévas M, Ebbo M, Audia S, Bonnotte B, Schleinitz N, Durand JM, Chiche L, Khellaf M, Bierling P, Roudot-Thoraval F, Godeau B, Michel M. Mahévas M, et al. Among authors: bierling p. Am J Hematol. 2013 Oct;88(10):858-61. doi: 10.1002/ajh.23518. Epub 2013 Sep 3. Am J Hematol. 2013. PMID: 23798363 Free article. Clinical Trial.
The temporary use of thrombopoietin-receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study.
Mahévas M, Fain O, Ebbo M, Roudot-Thoraval F, Limal N, Khellaf M, Schleinitz N, Bierling P, Languille L, Godeau B, Michel M. Mahévas M, et al. Among authors: bierling p. Br J Haematol. 2014 Jun;165(6):865-9. doi: 10.1111/bjh.12888. Epub 2014 Apr 12. Br J Haematol. 2014. PMID: 24725224 Free article.
Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients.
Khellaf M, Charles-Nelson A, Fain O, Terriou L, Viallard JF, Cheze S, Graveleau J, Slama B, Audia S, Ebbo M, Le Guenno G, Cliquennois M, Salles G, Bonmati C, Teillet F, Galicier L, Hot A, Lambotte O, Lefrère F, Sacko S, Kengue DK, Bierling P, Roudot-Thoraval F, Michel M, Godeau B. Khellaf M, et al. Among authors: bierling p. Blood. 2014 Nov 20;124(22):3228-36. doi: 10.1182/blood-2014-06-582346. Epub 2014 Oct 7. Blood. 2014. PMID: 25293768 Free article. Clinical Trial.
Platelet autoantibodies and lupus-associated thrombocytopenia.
Michel M, Lee K, Piette JC, Fromont P, Schaeffer A, Bierling P, Godeau B. Michel M, et al. Among authors: bierling p. Br J Haematol. 2002 Nov;119(2):354-8. doi: 10.1046/j.1365-2141.2002.03817.x. Br J Haematol. 2002. PMID: 12406068 Free article.
204 results